Cerba launches €408m add-on loan to fund Bio7 buyout: Reuters
European medical laboratory services operator Cerba Healthcare is raising an additional €408 million leveraged loan to back an acquisition of France-based clinical analysis specialist Groupe Bio7, banking sources told Reuters. Cerba announced that it had signed an exclusive agreement to buy Bio7 from French private equity firm Ardian last month. Cerba was last in Europe’s loan market in March 2017 when it raised a €794 million as part of a financing backing its acquisition by European private equity firm Partners Group and Canada’s Public Sector Pension Investment Board (PSP Investments).






